GRAIL, Inc. Common Stock (GRAL) is a publicly traded Healthcare sector company. As of October 21, 2026, GRAL trades at $132.99 with a market cap of $5.57B and a P/E ratio of -14.17. GRAL moved +6.30% today. Year to date, GRAL is +54.92%; over the trailing twelve months it is +44.37%. Its 52-week range spans $20.44 to $166.48. Analyst consensus is buy with an average price target of $128.67. Rallies surfaces GRAL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
GRAL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GRAL recently traded at $132.99. Market cap is $5.57B. P/E ratio is -14.17. Revenue is $165.26M.
| Metric | Value |
|---|---|
| Price | $132.99 |
| Market Cap | $5.57B |
| P/E Ratio |
| -14.17 |
| EPS | $-9.70 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $166.48 |
|---|
| 52-Week Low | $20.44 |
|---|
| Volume | 483.21K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $165.26M |
|---|
| Net Income | $-391.59M |
|---|
| Gross Margin | 0.00% |
|---|
10 analysts cover GRAL: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $128.67.